Core Viewpoint - The company has successfully canceled its supervisory board and revised its articles of association, reflecting a significant governance change aimed at streamlining operations and enhancing decision-making efficiency [1][2]. Group 1: Corporate Governance Changes - The company held its second extraordinary general meeting of shareholders on September 9, 2025, where the proposal to cancel the supervisory board and amend the articles of association was approved [1]. - The company has completed the necessary business registration changes and filed the revised articles of association, receiving a new business license from the Guangzhou Market Supervision Administration [1]. Group 2: Company Information - The company is officially named Guangzhou Kingmed Diagnostics Group Co., Ltd., with a unified social credit code of 9144010178891443XK [1]. - The company is classified as a joint-stock company (listed, natural person investment or control) and is located at No. 10, Spiral Road, International Biological Island, Guangzhou [1]. - The registered capital of the company is 463,257,875 RMB, and it was established on May 26, 2006 [1]. - The company's business scope includes investment consulting, biotechnology development, software development, environmental monitoring, and various testing services [1].
广州金域医学检验集团股份有限公司 关于完成工商变更登记并换发营业执照的公告